Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2025)
Harmony Biosciences Holdings (HRMY) has disclosed Retained Earnings for 7 consecutive years, with $346000.0 as the latest value for Q4 2025.
- Quarterly Retained Earnings rose 424.24% to $346000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $346000.0 through Dec 2025, up 424.24% year-over-year, with the annual reading at $346000.0 for FY2025, 424.24% up from the prior year.
- Retained Earnings hit $346000.0 in Q4 2025 for Harmony Biosciences Holdings, down from $138.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $138.4 million in Q3 2025 to a low of -$480.8 million in Q1 2021.
- Historically, Retained Earnings has averaged -$146.7 million across 5 years, with a median of -$519000.0 in 2023.
- Biggest five-year swings in Retained Earnings: tumbled 1700.0% in 2023 and later surged 27638.88% in 2025.
- Year by year, Retained Earnings stood at -$453.6 million in 2021, then surged by 40.01% to -$272.1 million in 2022, then skyrocketed by 47.35% to -$143.3 million in 2023, then soared by 100.05% to $66000.0 in 2024, then surged by 424.24% to $346000.0 in 2025.
- Business Quant data shows Retained Earnings for HRMY at $346000.0 in Q4 2025, $138.4 million in Q3 2025, and $239000.0 in Q2 2025.